BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 233 filers reported holding BEAM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $351 | -80.1% | 10,996 | -80.9% | 0.02% | -81.0% |
| Q1 2023 | $1,762 | -35.4% | 57,556 | -17.5% | 0.12% | -39.5% |
| Q4 2022 | $2,729 | -99.9% | 69,783 | -6.8% | 0.20% | -27.8% |
| Q3 2022 | $3,569,000 | +35.9% | 74,914 | +10.4% | 0.28% | +40.6% |
| Q2 2022 | $2,627,000 | -44.9% | 67,875 | -18.5% | 0.20% | -32.5% |
| Q1 2022 | $4,771,000 | -24.3% | 83,264 | +5.2% | 0.29% | -18.4% |
| Q4 2021 | $6,306,000 | -0.4% | 79,128 | +8.7% | 0.36% | -7.7% |
| Q3 2021 | $6,334,000 | -30.8% | 72,798 | +2.4% | 0.39% | -30.8% |
| Q2 2021 | $9,152,000 | +69.5% | 71,105 | +5.4% | 0.56% | +55.8% |
| Q1 2021 | $5,399,000 | -3.7% | 67,452 | -1.8% | 0.36% | -6.0% |
| Q4 2020 | $5,608,000 | +287.0% | 68,689 | +16.7% | 0.38% | +242.0% |
| Q3 2020 | $1,449,000 | – | 58,861 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |